Notices and Activity Reports

【Report】Participated in the 3rd Annual Meeting of the Japanese Society of Preemptive Clinical Medicin

THE 3RD ANNUAL CONFERENCE OF THE JAPANESE SOCIETY OF PREEMPTIVE CLINICAL MEDICINE “JSPCM KOBE 2019” WAS HELD IN KOBE, HYOGO, JAPAN ON NOVEMBER 16-17, 2019.

The Japanese Society of Preemptive Clinical Medicine was established in April 2018, and many of our members serve on the board of directors, so many doctors were present on this day.

This year we also participated in poster presentations, and many people were able to see the results of our daily research.
As case reports, Dr. Yuichi Kawai (Director, Kawai Internal Medicine Clinic ) presented a case of irritable bowel syndrome, Dr. Masahiko Shirotani (Director, Luke’s Ashiya Clinic ) presented a case of atopic dermatitis, and the Symbiosis Institute presented a comparison of transplanted diabetic monotypic mice and Japan’s only [ In addition, the Symbiosis Institute exhibited the “Ultra Fine Bubble Water Mechanism” used for the purification of bacterial solution, for which a patent has been applied for.

Dr. Masahiko Shirotani (Director, Luke’s Ashiya Clinic ) gave a lecture from our study group, and Dr. Zen Tanaka (Director, Tanaka Clinic ), Representative Director, and Dr. Noriaki Man (Director, Yorozu Clinic ), Director, served as chairpersons. Regular members Dr. Yuichi Kawai (Director, Kawai Internal Medicine Clinic ) and Dr. Katsuhiko Fukuda (Vice Director, Fukuda Internal Medicine Clinic ) also participated.

Dr. Masahiko Shirotani, Director, Luke’s Ashiya Clinic
Dr. Zen Tanaka, Director, Tanaka Clinic
Dr. Noriaki Man, Director, Yorozu Clinic
Dr. Katsuhiko Fukuda, Deputy Director, Fukuda Internal Medicine Clinic
Dr. Yuichi Kawai, Director, Kawai Internal Medicine Clinic, and Makoto Shimizu, Symbiosis Institute

We were able to catch a glimpse of the steady activities that are creating a paradigm shift in the field of medicine. Next year’s event will be held in Tokyo from October 31 (Sat.) to November 1 (Sun.).

日本先制臨床医学会のホームページはこちら

Articles about other Notices and Activity Reports

November 16, 2026

10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]

The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 06, 2026

Survey Summary from the 10th Annual Academic Conference

The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

October 28, 2024

〈Clinical Trial〉Completion Report

We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]